<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:0cm;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:36.0pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:36.0pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle19
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle20
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle21
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:826750574;
mso-list-type:hybrid;
mso-list-template-ids:-1286710820 201916417 201916419 201916421 201916417 201916419 201916421 201916417 201916419 201916421;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-AU" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal" align="center" style="text-align:center"><u><span lang="EN-US" style="font-size:12.0pt;line-height:105%;font-family:"Times New Roman",serif">International Journal of Drug Policy<o:p></o:p></span></u></p>
<p class="MsoNormal" align="center" style="text-align:center;line-height:normal">
<span lang="EN-US" style="font-size:10.0pt;font-family:"Times New Roman",serif">Call for papers<o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="text-align:center;line-height:normal">
<span lang="EN-US" style="font-size:10.0pt;font-family:"Times New Roman",serif"><o:p> </o:p></span></p>
<p class="MsoNormal" align="center" style="text-align:center;line-height:normal">
<span lang="EN-US" style="font-size:10.0pt;font-family:"Times New Roman",serif">Themed collection:</span><span lang="EN-US" style="font-family:"Times New Roman",serif">
<b>Drugged pleasures<o:p></o:p></b></span></p>
<p class="MsoNormal" align="center" style="text-align:center;line-height:normal">
<b><span lang="EN-US" style="font-size:12.0pt;font-family:"Times New Roman",serif"><o:p> </o:p></span></b></p>
<p class="MsoNormal" align="center" style="text-align:center"><span lang="EN-US" style="font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif">Guest editors: Fay Dennis and Adrian Farrugia<o:p></o:p></span></p>
<p class="MsoNormalCxSpMiddle" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;line-height:normal">
<span lang="EN-US" style="font-family:"Times New Roman",serif">The marginality of accounts of pleasure in alcohol and other drug (AOD) research, intervention, policy and public discourse is an ongoing concern for AOD researchers. Explored in depth in this journal
eight years ago (Treloar and Holt, 2008), this themed collection intends to revisit some of these issues in light of broader conceptual shifts within
</span><span style="font-family:"Times New Roman",serif">qualitative AOD research</span><span lang="EN-US" style="font-family:"Times New Roman",serif"> towards what can be loosely categorised as ‘new material’ theories</span><span style="font-family:"Times New Roman",serif">.
Drawing from </span><span lang="EN-US" style="font-family:"Times New Roman",serif">perspectives such as actor-network theory, science and technology studies, Deleuze and Guattari’s (1987) ‘assemblages’ and Barad’s (2007) ‘agential realism’, researchers are
increasingly focusing on relationality, emergence, specific ‘events’ of consumption and the contingency of drug effects. These theories seek to decentre the ontological primacy of the anterior human subject and the notion of stable drug objects, and draw attention
to the provisional enactment of AOD realities in research, policy and consumption itself. The turn to new materialisms raises new questions about how to most effectively approach pleasure in AOD consumption, the significance of such a focus, and how to best
conceptualise it. </span><span style="font-family:"Times New Roman",serif">This themed collection will consider what new material approaches have to offer our understandings of pleasure in AOD consumption, policy, and practice.<o:p></o:p></span></p>
<p class="MsoNormalCxSpMiddle" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;line-height:normal">
<span style="font-family:"Times New Roman",serif"><o:p> </o:p></span></p>
<p class="MsoNormalCxSpMiddle" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;line-height:normal">
<span style="font-family:"Times New Roman",serif">We welcome submissions from a wide disciplinary area, drawing on a variety of novel concepts and methods. We encourage a mix of paper types, including commentaries, reviews or critical essays, as well as empirical
case studies. Possible topics include, but are not limited to the following:<o:p></o:p></span></p>
<p class="MsoNormalCxSpLast" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;line-height:normal">
<span style="font-family:"Times New Roman",serif"><o:p> </o:p></span></p>
<p class="MsoListParagraphCxSpFirst" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo2">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-AU"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-family:"Times New Roman",serif;mso-fareast-language:EN-AU">Theorising and studying the emergence of pleasure beyond bodily boundaries; <o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo2">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-AU"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-family:"Times New Roman",serif;mso-fareast-language:EN-AU">Analysing how pleasure is assembled and made in consumption practices; <o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo2">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-AU"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-family:"Times New Roman",serif;mso-fareast-language:EN-AU">Examining how drugged pleasures can inform harm reduction;<o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo2">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-AU"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-family:"Times New Roman",serif;mso-fareast-language:EN-AU">Exploring how attuning to pleasure can produce more embodied and sensitive research and treatment practices;<o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo2">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-AU"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-family:"Times New Roman",serif;mso-fareast-language:EN-AU">Exploring how pleasure is constrained/contained, made or enacted in policy, health interventions and treatment practices;
<o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo2">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-AU"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-family:"Times New Roman",serif;mso-fareast-language:EN-AU">Continuing discussions of the singular focus on harm; <o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo2">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-AU"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-family:"Times New Roman",serif;mso-fareast-language:EN-AU">Investigating the blur between notions of pleasure and danger in drug consumption;<o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo2">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-AU"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-family:"Times New Roman",serif;mso-fareast-language:EN-AU">Considering whether the focus on pleasure in AOD research is fulfilling the potential researchers argue for;<o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo2">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-AU"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-family:"Times New Roman",serif;mso-fareast-language:EN-AU">Developing concepts that could exceed pleasure in the ability to improve our understandings of the complexity of drug experiences;<o:p></o:p></span></p>
<p class="MsoListParagraphCxSpLast" style="margin-bottom:0cm;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo2">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-AU"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="font-family:"Times New Roman",serif;mso-fareast-language:EN-AU">Developing novel methods for analysing drugged pleasures, desires or practices of care.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span lang="EN-US" style="font-family:"Times New Roman",serif"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span lang="EN-US" style="font-family:"Times New Roman",serif">Commentary and Afterword
<o:p></o:p></span></b></p>
<p class="MsoNormal"><span lang="EN-US" style="font-family:"Times New Roman",serif">We are excited to announce that Associate Professor Helen Keane will contribute a Commentary, and Professor Carla Treloar and Associate Professor Martin Holt will offer an Afterword
to the collection. <o:p></o:p></span></p>
<p class="MsoNormal"><b><span lang="EN-US" style="font-family:"Times New Roman",serif">Guidelines for submission<o:p></o:p></span></b></p>
<p class="MsoNormal"><span lang="EN-US" style="font-family:"Times New Roman",serif">Abstracts (not to exceed 500 words) should be emailed to Fay Dennis (</span><a href="mailto:Fay.Dennis@lshtm.ac.uk"><span lang="EN-US" style="font-family:"Times New Roman",serif">Fay.Dennis@lshtm.ac.uk</span></a><span lang="EN-US" style="font-family:"Times New Roman",serif">)
and Adrian Farrugia (</span><a href="mailto:adrian.farrugia@curtin.edu.au"><span lang="EN-US" style="font-family:"Times New Roman",serif">adrian.farrugia@curtin.edu.au</span></a><span lang="EN-US" style="font-family:"Times New Roman",serif">) by
<b>21 November 2016</b>. The email subject should read ‘IJDP Themed Collection’. The editors will inform the authors by
<b>19 December 2016</b> whether to proceed to full submission. If accepted, full manuscripts should be submitted to the journal from
<b>10 February to 20 April 2017</b>. </span><span style="font-family:"Times New Roman",serif">All manuscripts are subject to the usual
<i>IJDP</i> peer review process. For more information on types of submissions see
</span><a href="https://www.elsevier.com/journals/international-journal-of-drug-policy/0955-3959/guide-for-authors"><span style="font-family:"Times New Roman",serif">https://www.elsevier.com/journals/international-journal-of-drug-policy/0955-3959/guide-for-authors</span></a><span style="font-family:"Times New Roman",serif">
<o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>